We are live on ! Find out more
GEN

Genesis Healthcare, Inc.
GEN

Delisted

GEN was delisted on the 25th of March, 2021.

67 hedge funds and large institutions have $45M invested in Genesis Healthcare, Inc. in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 23 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% more capital invested

Capital invested by funds: $22.6M → $45M (+$22.5M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

9% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 11

1% less funds holding

Funds holding: 6867 (-1)

30% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 23

Holders
67
Holders Change
-1
Holders Change %
-1.47%
% of All Funds
1.54%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
16
Reduced
23
Closed
11
Calls
$40K
Puts
Net Calls
+$40K
Net Calls Change
+$40K
Name Holding Trade Value Shares
Change
Change in
Stake
Tudor Investment Corp
51
Tudor Investment Corp
Connecticut
$21K
Commonwealth Equity Services
52
Commonwealth Equity Services
Massachusetts
$21K +$16.9K +14,446 New
BNP Paribas Financial Markets
53
BNP Paribas Financial Markets
France
$19.4K -$373 -318 -2%
GCP
54
GSA Capital Partners
United Kingdom
$18K
Wolverine Trading
55
Wolverine Trading
Illinois
$17K -$5.77K -4,924 -30%
Bank of America
56
Bank of America
North Carolina
$17K -$129 -110 -1%
IC
57
Iconiq Capital
California
$17K
PPA
58
Parametric Portfolio Associates
Washington
$17K +$13.4K +11,473 New
Principal Financial Group
59
Principal Financial Group
Iowa
$16K -$8.25K -7,044 -40%
FDCDDQ
60
Federation des caisses Desjardins du Quebec
Quebec, Canada
$15.1K
Manulife (Manufacturers Life Insurance)
61
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$12K -$9.96K -8,498 -51%
Legal & General Group
62
Legal & General Group
United Kingdom
$9K -$3.59K -3,066 -35%
Citigroup
63
Citigroup
New York
$8K +$1.39K +1,189 +26%
AIP
64
Ameritas Investment Partners
Nebraska
$4K
MAM
65
Meeder Asset Management
Ohio
$2K -$1.48K -1,262 -49%
VF
66
Virtu Financial
New York
-$203K -266,657 Closed
Invesco
67
Invesco
Georgia
-$108K -142,133 Closed
SG Americas Securities
68
SG Americas Securities
New York
-$78K -101,966 Closed
OAM
69
Oxford Asset Management
United Kingdom
-$45K -58,234 Closed
Citadel Advisors
70
Citadel Advisors
Florida
-$20K -26,805 Closed
PIA
71
Phoenix Investment Adviser
New York
-$18K -23,944 Closed
Balyasny Asset Management
72
Balyasny Asset Management
Illinois
-$12K -15,225 Closed
TRCT
73
Tower Research Capital (TRC)
New York
-$9K -12,346 Closed
Parallax Volatility Advisers
74
Parallax Volatility Advisers
California
-$4K -5,544 Closed
Federated Hermes
75
Federated Hermes
Pennsylvania
-$2K -2,733 Closed

GEN Hedge Fund Activity: Q1 2018 in Review

67 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q1 2018, worth a combined $45M — up 99% from $22.6M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of GEN and 10 opened new positions — a net loss of 1 holder — while 23 trimmed existing stakes and 16 added.

The largest buyer was Glassman Wealth Services, opening a new position worth an estimated $1.29M. The largest seller was Prescott Group Capital Management, cutting an estimated $1.96M.

  • 67 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q1 2018, down from 68 in Q4 2017.
  • Funds reported $45M of Genesis Healthcare, Inc. stock for Q1 2018, up 99% quarter-over-quarter.
  • 10 funds opened new Genesis Healthcare, Inc. positions in Q1 2018 and 11 closed out, a net change of -1 holder.
  • The largest Genesis Healthcare, Inc. buyer in Q1 2018 was Glassman Wealth Services, an estimated $1.29M added.
  • The largest Genesis Healthcare, Inc. seller in Q1 2018 was Prescott Group Capital Management, an estimated $1.96M sold.

Based on aggregated 13F filings for Q1 2018.